Skip to main content

BMEA

Stock
Health Care
Biotechnology

Performance overview

BMEA Price
Price Chart

Forward-looking statistics

Beta
0.66
Risk
97.43%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Company info

SectorHealth Care
IndustryBiotechnology
Employees93
Market cap$148.8M

Fundamentals

Enterprise value$39.7M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity27.59

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.54
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$8M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth-7.5
Credit+8.5
Liquidity+4.5
Inflation-7.3
Commodities-4.3
Interest Rates-0.5

Valuation

Dividend yield0.00%
PEG Ratio-0.50
Price to sales—
P/E Ratio-0.50
Enterprise Value to Revenue—
Price to book2.17

Upcoming events

Next earnings dayAugust 1, 2024
Next dividend day—
Ex. dividend day—

News

Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know

Biomea Fusion (BMEA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research (June 3, 2025)
Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?

On Tuesday, Biomea Fusion Inc. BMEA revealed topline results from the ongoing COVALENT-111 study of icovamenib in patients with type 2 diabetes (T2D).

Benzinga (December 17, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free